Alector (United States)

company in San Francisco, United States

ALEC Nasdaq SEC CIK 1653087
Follow Alector (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $162.9M +4895.9% vs same quarter last year
Net income $124.6M +459.4% vs same quarter last year
EPS, diluted $1.11 +426.5% vs same quarter last year
Operating cash flow −$24.2M +25.7% vs same quarter last year
Revenue by quarter
$54.2M
$3.7M
$7.9M
$3.3M
$6.2M
$1M
$3.3M
$162.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200M$300MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$21M−$143M
FY24$100.6M−$119M
FY23$97.1M−$130M
FY22$133.6M−$133.3M
FY21$207.1M−$36.3M
FY20$21.1M−$190.2M
FY19$21.2M−$105.4M
FY18$27.5M−$52.2M
FY17$2.9M−$32.5M
FY16--
MarginsShare of revenue
  • Operating margin
  • Net margin
−1500%−1000%−500%0%FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−741.3%−679.5%
FY24−144.2%−118.3%
FY23−156.3%−133.9%
FY22−103.2%−99.8%
FY21−18%−17.5%
FY20−925.1%−901.6%
FY19−539.2%−496.7%
FY18−208.3%−189.9%
FY17−1137.8%−1130.9%
FY16--
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200M$400MFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$184.1M
FY24−$231.2M
FY23−$186.5M
FY22−$24.4M
FY21$295.3M
FY20−$171.8M
FY19−$114.6M
FY18$125.6M
FY17−$18.6M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Alector (United States)
  • Healthcare median
−1500%−1000%−500%0%FY17FY19FY21FY23FY25
Show the numbers
YearAlector (United States)Healthcare median
FY25−679.5%−30.6%
FY24−118.3%−47%
FY23−133.9%−58%
FY22−99.8%−80.4%
FY21−17.5%−71.8%
FY20−901.6%−62.2%
FY19−496.7%−46.2%
FY18−189.9%−49.6%
FY17−1130.9%−45.9%
FY16-−36%